Chemerin in renal dysfunction and cardiovascular disease

Area of Science:

• Biochemistry
• Nephrology
• Endocrinology

Background:

• Chemerin's role in cardiovascular and renal dysfunction is gaining recognition.
• Links exist between chemerin, inflammation, atherosclerosis, and metabolic parameters like obesity, insulin resistance, and blood glucose/lipid levels.
• Numerous studies have explored circulating chemerin levels in chronic kidney disease (CKD) populations.

Purpose of the Study:

• To investigate the pathophysiologic significance of chemerin in CKD.
• To address the knowledge gap regarding whether elevated chemerin causes or reflects diminished renal function.
• To highlight the need for better tools to understand chemerin's role.

Main Methods:

• Review of existing literature on chemerin and kidney disease.
• Discussion of the challenges posed by the lack of specific antibodies for different chemerin isoforms.
• Emphasis on the need for advanced technologies for measuring bioactive serum concentrations and tissue-specific isoform formation.

Main Results:

• Chemerin is associated with various cardiovascular and metabolic risk factors relevant to kidney disease.
• The causal relationship between chemerin levels and renal function decline remains unclear.
• Current limitations in detecting specific chemerin isoforms hinder a comprehensive understanding.

Conclusions:

• Understanding the precise role of chemerin in kidney disease pathophysiology requires further investigation.
• Accurate measurement of bioactive chemerin and its isoforms is crucial.
• Chemerin may potentially serve as a diagnostic or therapeutic marker in kidney disease if its role is clarified.